What Changed
Price Move History
- Daily moves over 5%
- 85 253 sessions, November 30, 2021 to November 30, 2022
- Largest daily move
- +88.2% close of October 18, 2022
- 1-year change
- +72.8% closing prices, November 30, 2021 to November 30, 2022
- 1-month change
- +0.9% closing prices, October 28, 2022 to November 30, 2022
Company Description
Akouos (NASDAQ: AKUS) is classified in the biotechnology industry within the Healthcare sector.
AKUS gained 72.8% in the 12 months to November 30, 2022. The last closing price was $13.29.
This page collects what Stock Titan holds for AKUS, including price data and latest news.
Stock Performance
Akouos (AKUS) closed at $13.29 on November 30, 2022. In the 12 months to November 30, 2022, the price gained 72.8%.
See what a $1,000 investment in AKUS was worth at its last close
AKUS Metrics & Rankings
Price returns through November 30, 2022. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Akouos has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, earnings, clinical trial, fda approval, conferences. View all AKUS news →
SEC Filings
AKUS Company Profile & Sector Positioning
Akouos (AKUS) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing AKUS often look at related companies in the same sector, including Vertex Pharmaceuticals Inc (VRTX), Regeneron Pharmaceuticals Inc (REGN), Moderna, Inc. (MRNA), argenx SE (ARGX), and BeOne Medicines Ltd. (ONC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AKUS's relative position within its industry.